CMV-Specific CD8+T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation.

被引：0
|
作者：
Meesing, A. [1 ]
Abraham, R. [2 ]
Razonable, R. [1 ]
机构：
[1] Mayo Clin, Div Infect Dis, Rochester, MN USA
[2] Mayo Clin, Lab Med & Pathol, Rochester, MN USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C315
引用
收藏
页码：877 / 877
页数：1
相关论文
共 50 条
  • [41] CMV-Specific CD154+T-Cells and CMV Disease Status After Liver Or Intestine Transplantation (LTx, ITx)
    Ashokkumar, C.
    Ningappa, M.
    Mazariegos, G.
    Soltys, K.
    Bond, G.
    Trautz, C.
    Green, M.
    Michaels, M.
    Sindhi, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [42] Emergence of a CD4+CD28- granzyme B+, CMV-specific T cell subset after recovery of primary CMV-infection
    van Leeuwen, EMM
    Remmerswaal, EBM
    van Lier, RAW
    ten Berge, IJM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 466 - 466
  • [43] Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
    Camargo, Jose F.
    Wieder, Eric
    Kimble, Erik
    Benjamin, Cara
    Kolonias, Despina
    Bravo, Gabriela
    Komanduri, Krishna
    BLOOD, 2017, 130
  • [44] Functional Signatures Revealed by Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation After Allogeneic Hematopoietic Cell Transplantation
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 15 - 16
  • [45] Profound T cell depletion does not eradicate CMV specific CD8 T cells responsible for protective immunity to CMV after T cell depleted allogeneic stem cell transplantation.
    van der Heiden, Pim L. J.
    Kalpoe, Jayant S.
    Haarman, Wilmy M. E.
    Opdam, Sonja M.
    Willemze, Roelof
    Falkenburg, J. H. Frederik
    Marijt, Erik W. A.
    BLOOD, 2006, 108 (11) : 826A - 827A
  • [46] Lack of CMV-specific CD4+ T-cell response after allogeneic stem cell transplantation is a risk factor for CMV organ manifestation
    Campe, H
    Gerbitz, A
    Kolb, H
    Koszinowski, U
    Jäger, G
    BONE MARROW TRANSPLANTATION, 2006, 37 : S31 - S32
  • [47] Functional Signatures Revealed by Deep Phenotyping of CMV-Specific CD8+T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
    Camargo, Jose F.
    Wieder, Eric
    Kimble, Erik
    Benjamin, Cara L.
    Kolonias, Despina
    Bravo, Gabriela
    Komanduri, Krishna V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S88 - S88
  • [48] Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation
    Pei, Xu-Ying
    Liu, Xue-Fei
    Zhao, Xiang-Yu
    Lv, Meng
    Mo, Xiao-Dong
    Chang, Ying-Jun
    Shang, Qian-Nan
    Sun, Yu-Qian
    Chen, Yu-Hong
    Xu, Lan-Ping
    Wang, Yu
    Zhang, Xiao-Hui
    Liu, Kai-Yan
    Huang, Xiao-Jun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (04) : 482 - 491
  • [49] Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation
    Xu-Ying Pei
    Xue-Fei Liu
    Xiang-Yu Zhao
    Meng Lv
    Xiao-Dong Mo
    Ying-Jun Chang
    Qian-Nan Shang
    Yu-Qian Sun
    Yu-Hong Chen
    Lan-Ping Xu
    Yu Wang
    Xiao-Hui Zhang
    Kai-Yan Liu
    Xiao-Jun Huang
    Cellular & Molecular Immunology, 2022, 19 : 482 - 491
  • [50] CMv-Specific CD8 T Cell Differentiation and Localization: implications for Adoptive Therapies
    Smith, Corinne J.
    Quinn, Michael
    Snyder, Christopher M.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
12345